Sodium butyrate aggravates glucose dysregulation and dyslipidemia in high fat-fed Wistar rats
暂无分享,去创建一个
[1] E. Claudio,et al. High-Fat Diet-Induced Obesity Model Does Not Promote Endothelial Dysfunction via Increasing Leptin/Akt/eNOS Signaling , 2019, Front. Physiol..
[2] Lin Li,et al. Sodium butyrate ameliorates lipopolysaccharide‐induced cow mammary epithelial cells from oxidative stress damage and apoptosis , 2018, Journal of cellular biochemistry.
[3] Yuan-qiang Lu,et al. VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes , 2018, Medicine.
[4] Arijit Ghosh,et al. Role of free fatty acids in endothelial dysfunction , 2017, Journal of Biomedical Science.
[5] K. Ramana,et al. Aspalatone Prevents VEGF-Induced Lipid Peroxidation, Migration, Tube Formation, and Dysfunction of Human Aortic Endothelial Cells , 2017, Oxidative medicine and cellular longevity.
[6] J. Miyoshi,et al. The gut microbiota and inflammatory bowel diseases. , 2017, Translational research : the journal of laboratory and clinical medicine.
[7] J. Romijn,et al. Gut Microbiota in Obesity and Undernutrition. , 2016, Advances in nutrition.
[8] Jun Jiang,et al. Function and clinical implications of short‐chain fatty acids in patients with mixed refractory constipation , 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[9] T. Matozaki,et al. Promotion of Intestinal Epithelial Cell Turnover by Commensal Bacteria: Role of Short-Chain Fatty Acids , 2016, PloS one.
[10] A. Margolles,et al. Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health , 2016, Front. Microbiol..
[11] A. Rezaei,et al. Metabolites of Dietary Protein and Peptides by Intestinal Microbes and their Impacts on Gut. , 2015, Current protein & peptide science.
[12] S. Davis,et al. Acute effects of hyperinsulinemia and hyperglycemia on vascular inflammatory biomarkers and endothelial function in overweight and obese humans. , 2015, American journal of physiology. Endocrinology and metabolism.
[13] Jaspinder Kaur. A Comprehensive Review on Metabolic Syndrome , 2014, Cardiology research and practice.
[14] S. Garcia,et al. Evaluation of lipid damage related to pathological and physiological conditions , 2013, Drug and chemical toxicology.
[15] A. Mesripour,et al. Impact of Sumac on postprandialhigh-fat oxidative stress , 2013 .
[16] T. Felix,et al. Prepartum dietary energy source fed to beef cows: II. Effects on progeny postnatal growth, glucose tolerance, and carcass composition. , 2012, Journal of animal science.
[17] T. Ulven. Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets , 2012, Front. Endocrin..
[18] S. Bir,et al. Redox balance dynamically regulates vascular growth and remodeling. , 2012, Seminars in cell & developmental biology.
[19] Napoleone Ferrara,et al. Developmental and pathological angiogenesis. , 2011, Annual review of cell and developmental biology.
[20] Kai Chen,et al. Inhibition of Reactive Oxygen Species by Lovastatin Downregulates Vascular Endothelial Growth Factor Expression and Ameliorates Blood-Retinal Barrier Breakdown in db/db Mice , 2010, Diabetes.
[21] D. Lewkowicz,et al. Narrowing of intersensory speech perception in infancy , 2009, Proceedings of the National Academy of Sciences.
[22] Morihiro Matsuda,et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.
[23] R. Alexander,et al. Reactive oxygen species as mediators of angiogenesis signaling. Role of NAD(P)H oxidase , 2004, Molecular and Cellular Biochemistry.
[24] P. Calder,et al. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. , 2003, Life sciences.
[25] K. Žarković. 4-hydroxynonenal and neurodegenerative diseases. , 2003, Molecular aspects of medicine.
[26] L. Carreras,et al. Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies , 2001, British journal of haematology.
[27] M. Ahmed,et al. New scope in angiogenesis: role of vascular endothelial growth factor (VEGF), NO, lipid peroxidation, and vitamin E in the pathophysiology of pre-eclampsia among Egyptian females. , 2001, Clinical biochemistry.
[28] N. Tamura,et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. , 1998, Circulation.
[29] M. Runge,et al. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. , 1997, Circulation research.